PPT-Prescribing Buprenorphine in Primary Care

Julie Kmiec DO Assistant Professor of Psychiatry University of Pittsburgh kmiecjupmcedu April 10 2018 1 Objectives Review prevalence of opioid use disorders Discuss the unmet needs for those with OUD. 55 4 Guidelinesformanagementheroin withdrawal5 Complicationsadversebuprenorphineevents6 Prescribing buprenorphine 2 Entrybuprenorphine treatment in the Maintenance Treatment of Opioid Dependence This 55 4 Guidelinesformanagementheroin withdrawal5 Complicationsadversebuprenorphineevents6 Prescribing buprenorphine 2 Entrybuprenorphine treatment in the Maintenance Treatment of Opioid Dependence This Identifying . indicators of good prescribing and problem use in . primary care. Nicola . Torrance. Research Fellow. Chronic Pain Research . Group. http. ://medicine.dundee.ac.uk/chronic-pain. . Adverse effects. C. linical Commissioning Group (CCG). About Us. Statutory public body. - April 2013. Organisation . Population 122,066. Budget £127m. Statutory duties. Our Priorities. Commission services that improve health of the whole population with better quality of care and outcomes for all patients. Daryl Shorter, MD. Staff Psychiatrist. Michael E. . DeBakey. VA Medical Center. March 2, 2017. Objectives . - By the completion of the presentation, learners will be able to:. (1) List risk factors for misuse, diversion, and/or dependence upon opioid medications and benzodiazepines. Daryl Shorter, MD. Staff Psychiatrist. Michael E. . DeBakey. VA Medical Center. March 2, 2017. Objectives . - By the completion of the presentation, learners will be able to:. (1) List risk factors for misuse, diversion, and/or dependence upon opioid medications and benzodiazepines. Molly Rutherford, MD. Family Physician. Bluegrass Family Wellness. Crestwood, KY. I have no commercial interests to disclose. Learning Objectives. Review the ASAM decision making guidelines. Explain how to obtain a DEA waiver. Sujo . Anathhanam . Megan Humphreys. academy@yhahsn.nhs.uk / 01274 383966. www.improvementacademy.org. #. WeStopMeds. Polypharmacy: the problem. 1/3. of ≥ 75 year olds are taking at least six medicines.. Therapy. Opioids. and HIV. You may know that…. Injection drug use (IDU), either directly or via sexual contact with an IDU partner, accounts for one-third of the cumulative estimated AIDS cases in the U.S.. Haley Pals, PharmD, BCPP. Tomah VA Medical Center, Tomah WI. ECHO January 6. th. , 2022. Objectives . Recognize the possible routes of training for pharmacists. Identify various established buprenorphine collaborations. Diana Deister, MS, MD. Child and Adolescent Psychiatrist. Adolescent Substance Use and Addictions Program. Division of Developmental Medicine. Boston Children’s Hospital. October 24. th. , . 2017. Disclosure. For Providers and Primary Care Teams. Medication Treatment for Opioid . U. se . D. isorder. Developer: . Joe Merrill, MD, University of . Washington,. Charles Morgan MD, and Anne . Griepp. MD, Western New York Collaborative. Nigel Dodds. Consultant Nurse. (Some of the) Issues around anticipatory prescribing in end of life care in the community. A focus on an audit of our practice. Learning and support for non-medical prescribers at St Christopher’s. Charlie Spencer. Lead . Advanced. . Clinical. . Practitioner. Cardiology. , . Warwick. Hospital (SWFT. ). @. cardiacchazz. https://www.facebook.com/groups/cardiologynurseforum. Sub Topics. What do non-medical prescribers need to support their role..